Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2023
Historique:
medline: 29 3 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

A larger thrombus in patients with acute ischemic stroke might result in more complex endovascular treatment procedures, resulting in poorer patient outcomes. Current evidence on thrombus volume and length related to procedural and functional outcomes remains contradicting. This study aimed to assess the prognostic value of thrombus volume and thrombus length and whether this relationship differs between first-line stent retrievers and aspiration devices for endovascular treatment. In this multicenter retrospective cohort study, 670 of 3279 patients from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) for endovascularly treated large vessel occlusions were included. Thrombus volume (0.1 mL) and length (0.1 mm) based on manual segmentations and measurements were related to reperfusion grade (expanded Treatment in Cerebral Infarction score) after endovascular treatment, the number of retrieval attempts, symptomatic intracranial hemorrhage, and a shift for functional outcome at 90 days measured with the reverted ordinal modified Rankin Scale (odds ratio >1 implies a favorable outcome). Univariable and multivariable linear and logistic regression were used to report common odds ratios (cORs)/adjusted cOR and regression coefficients (B/aB) with 95% CIs. Furthermore, a multiplicative interaction term was used to analyze the relationship between first-line device choice, stent retrievers versus aspiration device, thrombus volume, and outcomes. Thrombus volume was associated with functional outcome (adjusted cOR, 0.83 [95% CI, 0.71-0.97]) and number of retrieval attempts (aB, 0.16 [95% CI, 0.16-0.28]) but not with the other outcome measures. Thrombus length was only associated with functional independence (adjusted cOR, 0.45 [95% CI, 0.24-0.85]). Patients with more voluminous thrombi had worse functional outcomes if endovascular treatment was based on first-line stent retrievers (interaction cOR, 0.67 [95% CI, 0.50-0.89]; In this study, patients with a more voluminous thrombus required more endovascular thrombus retrieval attempts and had a worse functional outcome. Patients with a lengthier thrombus were less likely to achieve functional independence at 90 days. For more voluminous thrombi, first-line stent retrieval compared with first-line aspiration might be associated with worse functional outcome.

Sections du résumé

BACKGROUND
A larger thrombus in patients with acute ischemic stroke might result in more complex endovascular treatment procedures, resulting in poorer patient outcomes. Current evidence on thrombus volume and length related to procedural and functional outcomes remains contradicting. This study aimed to assess the prognostic value of thrombus volume and thrombus length and whether this relationship differs between first-line stent retrievers and aspiration devices for endovascular treatment.
METHODS
In this multicenter retrospective cohort study, 670 of 3279 patients from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) for endovascularly treated large vessel occlusions were included. Thrombus volume (0.1 mL) and length (0.1 mm) based on manual segmentations and measurements were related to reperfusion grade (expanded Treatment in Cerebral Infarction score) after endovascular treatment, the number of retrieval attempts, symptomatic intracranial hemorrhage, and a shift for functional outcome at 90 days measured with the reverted ordinal modified Rankin Scale (odds ratio >1 implies a favorable outcome). Univariable and multivariable linear and logistic regression were used to report common odds ratios (cORs)/adjusted cOR and regression coefficients (B/aB) with 95% CIs. Furthermore, a multiplicative interaction term was used to analyze the relationship between first-line device choice, stent retrievers versus aspiration device, thrombus volume, and outcomes.
RESULTS
Thrombus volume was associated with functional outcome (adjusted cOR, 0.83 [95% CI, 0.71-0.97]) and number of retrieval attempts (aB, 0.16 [95% CI, 0.16-0.28]) but not with the other outcome measures. Thrombus length was only associated with functional independence (adjusted cOR, 0.45 [95% CI, 0.24-0.85]). Patients with more voluminous thrombi had worse functional outcomes if endovascular treatment was based on first-line stent retrievers (interaction cOR, 0.67 [95% CI, 0.50-0.89];
CONCLUSIONS
In this study, patients with a more voluminous thrombus required more endovascular thrombus retrieval attempts and had a worse functional outcome. Patients with a lengthier thrombus were less likely to achieve functional independence at 90 days. For more voluminous thrombi, first-line stent retrieval compared with first-line aspiration might be associated with worse functional outcome.

Identifiants

pubmed: 36912141
doi: 10.1161/STROKEAHA.122.041606
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1056-1065

Investigateurs

Diederik W J Dippel (DWJ)
Robert J van Oostenbrugge (RJ)
Jan Albert Vos (JA)
Ivo G H Jansen (IGH)
Maxim J H L Mulder (MJHL)
Robert-Jan B Goldhoorn (RB)
Kars C J Compagne (KCJ)
Josje Brouwer (J)
Sanne J den Hartog (SJ)
Wouter H Hinsenveld (WH)
Diederik W J Dippel (DWJ)
Bob Roozenbeek (B)
Adriaan C G M van Es (ACGM)
Jonathan M Coutinho (JM)
Wouter J Schonewille (WJ)
Jan Albert Vos (JA)
Marieke J H Wermer (MJH)
Marianne A A van Walderveen (MAA)
Julie Staals (J)
Robert J van Oostenbrugge (RJ)
Jeannette Hofmeijer (J)
Jasper M Martens (JM)
Geert J Lycklama À Nijeholt (GJ)
Sebastiaan F de Bruijn (SF)
Lukas C van Dijk (LC)
H Bart van der Worp (HB)
Rob H Lo (RH)
Ewoud J van Dijk (EJ)
Hieronymus D Boogaarts (HD)
J de Vries (J)
Paul L M de Kort (PLM)
Julia van Tuijl (J)
Jo P Peluso (JP)
Puck Fransen (P)
Jan S P van den Berg (JSP)
Boudewijn A A M van Hasselt (BAAM)
Leo A M Aerden (LAM)
René J Dallinga (RJ)
Maarten Uyttenboogaart (M)
Omid Eschgi (O)
Reinoud P H Bokkers (RPH)
Tobien H C M L Schreuder (THCML)
Roel J J Heijboer (RJJ)
Koos Keizer (K)
Lonneke S F Yo (LSF)
Heleen M den Hertog (HM)
Emiel J C Sturm (EJC)
Paul J A M Brouwers (PJAM)
Geert J Lycklama À Nijeholt (GJ)
Marianne A A van Walderveen (MAA)
Marieke E S Sprengers (MES)
René van den Berg (R)
Albert J Yoo (AJ)
Ludo F M Beenen (LFM)
Alida A Postma (AA)
Bas F W van der Kallen (BFW)
Ido R van den Wijngaard (IR)
Adriaan C G M van Es (ACGM)
Jasper M Martens (JM)
Lonneke S F Yo (LSF)
Jan Albert Vos (JA)
Joost Bot (J)
Pieter-Jan van Doormaal (PJ)
Anton Meijer (A)
Elyas Ghariq (E)
Reinoud P H Bokkers (RPH)
Marc P van Proosdij (MP)
G Menno Krietemeijer (GM)
Jo P Peluso (JP)
Hieronymus D Boogaarts (HD)
Rob Lo (R)
Dick Gerrits (D)
Wouter Dinkelaar (W)
Auke P A Appelman (APA)
Bas Hammer (B)
Sjoert Pegge (S)
Saman Vinke (S)
Diederik W J Dippel (DWJ)
Robert J van Oostenbrugge (RJ)
Geert J Lycklama À Nijeholt (GJ)
Jan Albert Vos (JA)
Wouter J Schonewille (WJ)
Jeannette Hofmeijer (J)
Jasper M Martens (JM)
H Bart van der Worp (HB)
Rob H Lo (RH)
Robert J van Oostenbrugge (RJ)
Jeannette Hofmeijer (J)
H Zwenneke Flach (HZ)
Hester F Lingsma (HF)
Naziha El Ghannouti (N)
Martin Sterrenberg (M)
Wilma Pellikaan (W)
Rita Sprengers (R)
Marjan Elfrink (M)
Michelle Simons (M)
Marjolein Vossers (M)
Joke de Meris (J)
Tamara Vermeulen (T)
Annet Geerlings (A)
Gina van Vemde (G)
Tiny Simons (T)
Gert Messchendorp (G)
Nynke Nicolaij (N)
Hester Bongenaar (H)
Karin Bodde (K)
Sandra Kleijn (S)
Jasmijn Lodico (J)
Hanneke Droste (H)
Maureen Wollaert (M)
Sabrina Verheesen (S)
D Jeurrissen (D)
Erna Bos (E)
Yvonne Drabbe (Y)
Michelle Sandiman (M)
Nicoline Aaldering (N)
Berber Zweedijk (B)
Jocova Vervoort (J)
Eva Ponjee (E)
Sharon Romviel (S)
Karin Kanselaar (K)
Denn Barning (D)
Esmee Venema (E)
Vicky Chalos (V)
Ralph R Geuskens (RR)
Tim van Straaten (T)
Saliha Ergezen (S)
Roger R M Harmsma (RRM)
Daan Muijres (D)
Anouk de Jong (A)
Olvert A Berkhemer (OA)
Anna M M Boers (AMM)
J Huguet (J)
P F C Groot (PFC)
Marieke A Mens (MA)
Katinka R van Kranendonk (KR)
Kilian M Treurniet (KM)
Manon L Tolhuisen (ML)
Heitor Alves (H)
Annick J Weterings (AJ)
Eleonora L F Kirkels (ELF)
Eva J H F Voogd (EJHF)
Lieve M Schupp (LM)
Sabine Collette (S)
Adrien E D Groot (AED)
Natalie E LeCouffe (NE)
Haryadi Prasetya (H)
Lucas A Ramos (LA)

Auteurs

Henk van Voorst (H)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Agnetha A E Bruggeman (AAE)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Jurr Andriessen (J)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Jan W Hoving (JW)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Praneeta R Konduri (PR)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Wenjin Yang (W)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China (W.Y.).

Manon Kappelhof (M)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Nerea Arrarte Terreros (N)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Yvo B W E M Roos (YBWEM)

Department of Neurology (Y.B.W.E.M.R.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Wim H van Zwam (WH)

Department of Radiology and Nuclear Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands (W.H.v.Z.).

Aad van der Lugt (A)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands (A.v.d.L.).

Anouk van der Hoorn (A)

Department of Radiology and Nuclear Imaging (A.v.d.H.), University Medical Center Groningen, the Netherlands.

Jelis Boiten (J)

Department of Neurology (J.B.), University Medical Center Groningen, the Netherlands.

Stefan Roosendaal (S)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Sjoerd Jenniskens (S)

Department of Radiology and Nuclear Medicine, Radboud UMC, Nijmegen, the Netherlands (S.J.).

Matthan W A Caan (MWA)

Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Henk A Marquering (HA)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of Biomedical Engineering and Physics (H.v.V., P.R.K., M.K., N.A.T., M.W.A.C., H.A.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Bart J Emmer (BJ)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Charles B L M Majoie (CBLM)

Department of Radiology and Nuclear Medicine (H.v.V., A.A.E.B., J.A., J.W.H., P.R.K., W.Y., M.K., N.A.T., S.R., H.A.M., B.J.E., C.B.L.M.M.), Amsterdam UMC, University of Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH